tiprankstipranks
DENTSPLY SIRONA (CH:DY2)
NASDAQ:DY2
Switzerland Market
DY2
DENTSPLY SIRONA
RESEARCH TOOLSreports

DENTSPLY SIRONA (DY2) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

DY2 Analyst Ratings

Hold
13Ratings
Hold
3 Buy
8 Hold
2 Sell
Based on 13 analysts giving stock ratings to
DENTSPLY
SIRONA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DY2 Stock 12 Month Forecast

Average Price Target

$11.05
Based on 13 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $11.05 with a high forecast of $13.77 and a low forecast of $7.29. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$13.77Average Price Target$11.05Lowest Price Target$7.29
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:DY2
Michael Cherny
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
06/12/26
Analysts Conflicted on These Healthcare Names: United Therapeutics (NASDAQ: UTHR), DENTSPLY SIRONA (NASDAQ: XRAY) and Climb Bio (NASDAQ: CLYM)
Bank of America Securities Analyst forecast on CH:DY2
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF13.77
Buy
―
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on CH:DY2
Glen Santangelo
Barclays
Barclays
CHF9.72→CHF7.29
Sell
―
Assigned
06/05/26
Dentsply Sirona price target lowered to $9 from $12 at BarclaysDentsply Sirona price target lowered to $9 from $12 at Barclays
UBS Analyst forecast on CH:DY2
Kevin Caliendo
UBS
UBS
CHF14.58→CHF13.77
Buy
―
Assigned
05/07/26
Dentsply Sirona price target lowered to $17 from $18 at UBSDentsply Sirona price target lowered to $17 from $18 at UBS
Morgan Stanley Analyst forecast on CH:DY2
Erin Wright
Morgan Stanley
Morgan Stanley
CHF9.72
Hold
―
Reiterated
05/06/26
Hold Rating Maintained as Profitability Pressures Offset In‑Line Earnings and Long‑Term Targets
Stifel Nicolaus Analyst forecast on CH:DY2
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF11.34
Hold
―
Reiterated
05/06/26
Stifel Nicolaus Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Citi Analyst forecast on CH:DY2
Daniel Grosslight
Citi
Citi
CHF8.1→CHF8.5
Sell
―
Reiterated
05/06/26
DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Barrington Analyst forecast on CH:DY2
Michael Petusky
Barrington
Barrington
CHF13.77
Buy
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
Mizuho Securities Analyst forecast on CH:DY2
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF12.96→CHF11.34
Hold
―
Reiterated
05/06/26
Dentsply Sirona price target lowered to $14 from $16 at MizuhoDentsply Sirona price target lowered to $14 from $16 at Mizuho
Needham Analyst forecast on CH:DY2
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/06/26
Hold Rating Reaffirmed as FX-Driven Revenue Beat Offsets EPS Miss Amid Uneven ‘Return to Growth’ Path
Piper Sandler Analyst forecast on CH:DY2
Jason Bednar
Piper Sandler
Piper Sandler
CHF10.53
Hold
―
Reiterated
05/06/26
Piper Sandler Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
William Blair Analyst forecast on CH:DY2
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Reiterated
05/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and Jazz Pharmaceuticals (NASDAQ: JAZZ)
Evercore ISI Analyst forecast on CH:DY2
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF12.15→CHF10.53
Hold
―
Reiterated
04/08/26
Dentsply Sirona price target lowered to $13 from $15 at Evercore ISIDentsply Sirona price target lowered to $13 from $15 at Evercore ISI
Wells Fargo Analyst forecast on CH:DY2
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
CHF10.53
Hold
―
Reiterated
02/27/26
Wells Fargo Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
Robert W. Baird Analyst forecast on CH:DY2
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF9.72→CHF11.34
Hold
―
Reiterated
02/27/26
Dentsply Sirona price target raised to $14 from $12 at BairdDentsply Sirona price target raised to $14 from $12 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CH:DY2
Michael Cherny
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
06/12/26
Analysts Conflicted on These Healthcare Names: United Therapeutics (NASDAQ: UTHR), DENTSPLY SIRONA (NASDAQ: XRAY) and Climb Bio (NASDAQ: CLYM)
Bank of America Securities Analyst forecast on CH:DY2
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF13.77
Buy
―
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on CH:DY2
Glen Santangelo
Barclays
Barclays
CHF9.72→CHF7.29
Sell
―
Assigned
06/05/26
Dentsply Sirona price target lowered to $9 from $12 at BarclaysDentsply Sirona price target lowered to $9 from $12 at Barclays
UBS Analyst forecast on CH:DY2
Kevin Caliendo
UBS
UBS
CHF14.58→CHF13.77
Buy
―
Assigned
05/07/26
Dentsply Sirona price target lowered to $17 from $18 at UBSDentsply Sirona price target lowered to $17 from $18 at UBS
Morgan Stanley Analyst forecast on CH:DY2
Erin Wright
Morgan Stanley
Morgan Stanley
CHF9.72
Hold
―
Reiterated
05/06/26
Hold Rating Maintained as Profitability Pressures Offset In‑Line Earnings and Long‑Term Targets
Stifel Nicolaus Analyst forecast on CH:DY2
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF11.34
Hold
―
Reiterated
05/06/26
Stifel Nicolaus Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Citi Analyst forecast on CH:DY2
Daniel Grosslight
Citi
Citi
CHF8.1→CHF8.5
Sell
―
Reiterated
05/06/26
DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Barrington Analyst forecast on CH:DY2
Michael Petusky
Barrington
Barrington
CHF13.77
Buy
―
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
Mizuho Securities Analyst forecast on CH:DY2
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF12.96→CHF11.34
Hold
―
Reiterated
05/06/26
Dentsply Sirona price target lowered to $14 from $16 at MizuhoDentsply Sirona price target lowered to $14 from $16 at Mizuho
Needham Analyst forecast on CH:DY2
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/06/26
Hold Rating Reaffirmed as FX-Driven Revenue Beat Offsets EPS Miss Amid Uneven ‘Return to Growth’ Path
Piper Sandler Analyst forecast on CH:DY2
Jason Bednar
Piper Sandler
Piper Sandler
CHF10.53
Hold
―
Reiterated
05/06/26
Piper Sandler Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
William Blair Analyst forecast on CH:DY2
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Reiterated
05/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and Jazz Pharmaceuticals (NASDAQ: JAZZ)
Evercore ISI Analyst forecast on CH:DY2
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF12.15→CHF10.53
Hold
―
Reiterated
04/08/26
Dentsply Sirona price target lowered to $13 from $15 at Evercore ISIDentsply Sirona price target lowered to $13 from $15 at Evercore ISI
Wells Fargo Analyst forecast on CH:DY2
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
CHF10.53
Hold
―
Reiterated
02/27/26
Wells Fargo Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
Robert W. Baird Analyst forecast on CH:DY2
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF9.72→CHF11.34
Hold
―
Reiterated
02/27/26
Dentsply Sirona price target raised to $14 from $12 at BairdDentsply Sirona price target raised to $14 from $12 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

3 Months
Michael PetuskyBarrington
Success Rate
12/38 ratings generated profit
32%
Average Return
-5.61%
Copying Michael Petusky's trades and holding each position for 3 Months would result in 31.58% of your transactions generating a profit, with an average return of -5.61% per trade.
1 Year
Michael PetuskyBarrington
Success Rate
3/38 ratings generated profit
8%
Average Return
-23.93%
Copying Michael Petusky's trades and holding each position for 1 Year would result in 7.89% of your transactions generating a profit, with an average return of -23.93% per trade.
2 Years
Kevin CaliendoUBS
Success Rate
0/14 ratings generated profit
0%
Average Return
-31.71%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -31.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DY2 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
5
6
Buy
4
5
4
2
0
Hold
14
14
10
9
8
Sell
2
2
3
4
4
Strong Sell
0
0
0
0
0
total
20
21
17
20
18
In the current month, DY2 has received 6 Buy Ratings, 8 Hold Ratings, and 4 Sell Ratings. DY2 average Analyst price target in the past 3 months is 11.05.
Each month's total comprises the sum of three months' worth of ratings.

DY2 Financial Forecast

DY2 Earnings Forecast

Next quarter’s earnings estimate for DY2 is $0.28 with a range of $0.25 to $0.36. The previous quarter’s EPS was $0.22. DY2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for DY2 is $0.28 with a range of $0.25 to $0.36. The previous quarter’s EPS was $0.22. DY2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.

DY2 Sales Forecast

Next quarter’s sales forecast for DY2 is $708.67M with a range of $691.67M to $727.86M. The previous quarter’s sales results were $702.04M. DY2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.
Next quarter’s sales forecast for DY2 is $708.67M with a range of $691.67M to $727.86M. The previous quarter’s sales results were $702.04M. DY2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.

DY2 Stock Forecast FAQ

What is CH:DY2’s average 12-month price target, according to analysts?
Based on analyst ratings, DENTSPLY SIRONA’s 12-month average price target is 11.05.
    What is CH:DY2’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:DY2, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is DENTSPLY SIRONA a Buy, Sell or Hold?
        DENTSPLY SIRONA has a consensus rating of Hold, which is based on 3 buy ratings, 8 hold ratings and 2 sell ratings.
          What is DENTSPLY SIRONA’s share price target?
          The average share price target for DENTSPLY SIRONA is 11.05. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $13.77 ,and the lowest forecast is $7.29. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about DENTSPLY SIRONA?
            DENTSPLY SIRONA’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of DENTSPLY SIRONA?
              To buy shares of CH:DY2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.